Search

Your search keyword '"Valganciclovir"' showing total 1,221 results

Search Constraints

Start Over You searched for: Descriptor "Valganciclovir" Remove constraint Descriptor: "Valganciclovir" Topic medicine.disease Remove constraint Topic: medicine.disease
1,221 results on '"Valganciclovir"'

Search Results

1. Congenital cytomegalovirus infection in twin pregnancy

2. Epidemiology and long-term outcomes of cytomegalovirus DNAemia and disease in pediatric solid organ transplant recipients

3. Low-Dose Valganciclovir Prophylaxis Is Safe and Cost-Saving in CMV-Seropositive Kidney Transplant Recipients

4. Association of HHV-6 With Outcomes in CMV-seronegative Liver Transplant Recipients With CMV-seropositive Donors Receiving Preemptive Antiviral Therapy

5. Cytomegalovirus Encephalitis with Decreased Vision in Immunocompromised Patients Treated with Valganciclovir: Case Report

6. Congenital Cytomegalovirus Infection: Epidemiology, Timely Diagnosis, and Management

7. Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report

8. Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients

9. Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy

10. A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis

11. Atypical oral viral coinfection after allogeneic hematopoietic stem cell transplantation: Diagnosis and treatment challenge

12. Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab

13. Toxic epidermal necrolysis (Lyell’s syndrome) in a patient with HIV infection

14. Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia

15. Cytomegalovirus and the Liver Transplant Recipient

16. Pancreas-Kidney Transplantation: Do We Know the Frequency of Clinical Complications?

18. Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results

19. Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience

20. Management of cytomegalovirus corneal endotheliitis

21. Trichodysplasia spinulosa: a comprehensive review of the disease and its treatment

22. Cytomegalic inclusion disease of the newborn- A short review

23. Cytomegalovirus after kidney transplantation in 2020: moving towards personalized prevention

24. Cytomegalovirus Infection in Postrenal Transplant Recipients: 18 Years’ Experience From a Tertiary Referral Center

25. Congenital Cytomegalovirus Infection: Transmission, Diagnosis and Treatment

26. Valganciclovir therapy for a neonate with congenital cytomegalovirus pneumonitis

27. Cytomegalovirus disease in de novo kidney-transplant recipients: comparison of everolimus-based immunosuppression without prophylaxis with mycophenolic acid-based immunosuppression with prophylaxis

28. Antiviral treatment in congenital HCMV infection: The six-year experience of a single neonatal center in Poland

29. Efficacy and safety of oral valganciclovir in cytomegalovirus anterior uveitis with uncontrolled intraocular pressure

30. Low‐dose rituximab induction therapy is effective in immunological high‐risk renal transplantation without increasing cytomegalovirus infection

31. Cytomegalovirus Endotheliitis After Penetrating Keratoplasty

32. A case of cytomegalovirus esophagitis during topical steroid therapy for eosinophilic esophagitis

33. Cytomegalovirus infection during pregnancy: state of the science

34. Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future Directions

35. Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C

36. Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin

37. Prevention of cytomegalovirus infection after solid organ transplantation: a Bayesian network analysis

38. Congenital Cytomegalovirus—History, Current Practice, and Future Opportunities

39. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors

40. Refractory rheumatoid vasculitis complicated by cytomegalovirus reactivation as a manifestation of immune reconstitution inflammatory syndrome

41. Double trouble: concurrent cytomegalovirus and BK polyomavirus infections in a patient who underwent kidney transplantation

42. Comparison of prophylactic versus preemptive treatments in the management of cytomegalovirus infection in renal transplant recipients

43. Impact of cytomegalovirus serologic status on heart transplantation

44. New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation

45. Treatment of Cytomegalovirus Anterior Uveitis at a North American Tertiary Center With Oral Valganciclovir

46. ENDOGENOUS ASPERGILLUS ENDOPHTHALMITIS IN AN IMMUNOCOMPETENT PATIENT WITH A REMOTE HISTORY OF PULMONARY TUBERCULOSIS

47. Effects of valganciclovir on spermatogenesis in renal transplant patients – results of a multicenter prospective nonrandomized study

48. Atypical cytomegalovirus retinitis in an immunocompetent individual with diffuse large B-cell lymphoma posing a diagnostic enigma

49. The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis

Catalog

Books, media, physical & digital resources